How to Get Ozempic for $25 a Month: The Savings Card Path, Step by Step

Key Takeaways

• The $25 price exists, but only through the Novo Nordisk Ozempic Savings Offer, and only for patients with commercial insurance and a type 2 diabetes prescription.
• You must have commercial (employer or marketplace) insurance, not Medicare, Medicaid, TRICARE, or VA coverage.
• The savings card caps your copay at $25 per fill, with a maximum benefit of about $150 per fill, for up to 24 fills.
• If your insurance denies Ozempic, the $25 price collapses to either full cash price ($940 to $1,150) or the Novo Nordisk Patient Assistance Program (free, but income-capped).
• Compounded semaglutide through a state-licensed pharmacy is a separate path with predictable monthly pricing, often $179 to $279, no insurance involved.

Direct answer (40-60 words)

You can get Ozempic for $25 a month through the Novo Nordisk Ozempic Savings Offer if you have commercial insurance that covers the medication and a prescription for type 2 diabetes. The card lowers your monthly copay to $25, capped at roughly $150 in benefit per fill, for up to 24 fills.

Table of contents

1. The 30-second answer
2. What the $25 Ozempic offer actually is
3. Step by step: getting the $25 price
4. Who qualifies (and who is excluded)
5. What disqualifies you, even with the right insurance
6. What to do if your prior authorization is denied
7. Backup paths when the $25 offer doesn't work
8. The Novo Nordisk Patient Assistance Program (free Ozempic)
9. Compounded semaglutide as a separate option
10. FAQ
11. Sources
12. Footer disclaimers

What the $25 Ozempic offer actually is

The $25 price isn't a Walmart deal, a coupon site promotion, or a generic discount. It's the Novo Nordisk Ozempic Savings Offer, a manufacturer copay card published by the brand that owns Ozempic. The program reduces your insurance copay to as little as $25 per 28-day supply for eligible patients.

A copay card is not insurance. It works alongside your insurance. The pharmacist runs your insurance first, sees what your plan says you owe, then applies the savings card to lower that amount.

Three numbers matter here:

• $25 minimum: the lowest you'll pay per fill if eligible.
• About $150 maximum benefit per fill: the card subtracts up to roughly $150 from your copay. If your copay is $40, you pay $25. If your copay is $300, the card knocks it down to about $150.
• 24 fills total: the card stops working after 24 successful fills, which is roughly 24 months of weekly injections.

The exact maximum benefit can change year to year. As of April 2026, Novo Nordisk publishes a $150 per-fill cap on the Ozempic savings offer.

Step by step: getting the $25 price

The path from "I want Ozempic" to "I paid $25 at the pharmacy" has six steps. Most patients can complete it in two to three weeks, depending on prior authorization timing.

Step 1. Confirm a type 2 diabetes diagnosis with your provider. Ozempic is FDA-approved for type 2 diabetes, cardiovascular risk reduction in adults with type 2 diabetes and established heart disease, and chronic kidney disease in adults with type 2 diabetes (Marso et al., NEJM 2016). It is not FDA-approved for weight loss. The savings card requires a diabetes prescription. If your doctor writes Ozempic off-label for weight loss, the card doesn't apply, and most insurance plans will deny coverage.

Step 2. Get the prescription written. Your provider sends the prescription to your pharmacy, usually electronically. Make sure they use your correct insurance information.

Step 3. Verify Ozempic is on your formulary. Log into your insurance member portal and search the formulary for "semaglutide" or "Ozempic." Note the tier and any prior authorization (PA) requirement. Most commercial plans place Ozempic on Tier 3 or specialty, with a PA requirement (Yang et al., JAMA Internal Medicine 2024).

Step 4. Submit prior authorization if required. Your provider's office handles this. They submit documentation showing medical necessity: BMI, A1C, prior diabetes medications you've tried, and clinical rationale. Approval typically takes 3 to 14 business days. A 2024 GoodRx survey found 47% of new Ozempic prescriptions required PA, and 22% were denied on first submission.

Step 5. Activate the Novo Nordisk savings offer. Visit the Novo Nordisk Ozempic Savings page, confirm eligibility through their online questionnaire, and download the digital savings card. You can also get a physical card from your provider's office or by calling Novo Nordisk patient support.

Step 6. Bring both cards to the pharmacy. Hand the pharmacist your insurance card and the savings card together. The pharmacist runs them in sequence: insurance first, then the manufacturer card to reduce the resulting copay. If you're eligible and your insurance covers Ozempic, you walk out paying $25.

If the pharmacist tells you the savings card "didn't work," ask them to re-run the claim with the BIN and PCN numbers from the savings card. The most common rejection reason is a typo, not a real ineligibility.

Who qualifies (and who is excluded)

You qualify if:

• You have commercial (private) insurance through an employer, the ACA marketplace, or a private individual policy.
• Your insurance covers Ozempic (any copay amount, even $400+).
• Your prescription is for type 2 diabetes.
• You're a U.S. resident, age 18 or older.
• You're not enrolled in any government healthcare program.

You're excluded if:

• You have Medicare (Part D), Medicaid, TRICARE, VA, CHAMPVA, IHS, DOD, or any other government-funded prescription benefit.
• Your insurance doesn't cover Ozempic at all (the card cannot replace coverage, only reduce a copay).
• Your prescription is written off-label, including for weight loss.
• You live outside the U.S. or its territories.
• You've already used 24 fills under the program.

The Medicare exclusion is the most common surprise. By federal law (the Anti-Kickback Statute), drug manufacturers cannot offer copay assistance to patients enrolled in federal healthcare programs. This isn't a Novo Nordisk policy, it's a legal restriction that applies to every brand-name copay card in the U.S. (HHS OIG, 2014 Special Advisory Bulletin).

What disqualifies you, even with the right insurance

Three less obvious situations can knock you out of $25 eligibility.

Off-label prescription language. If your provider writes "for weight loss" anywhere on the prescription, the pharmacy claim flags it as off-label. The savings card rejects. The fix is to ensure your diagnosis code (E11.x for type 2 diabetes) is on the prescription, with appropriate documentation.

Plan with no Ozempic coverage. Some self-funded employer plans exclude GLP-1s entirely. If your formulary search returns "not covered," the savings card has nothing to discount, because there's no insurance copay to reduce. You'd pay full cash price, which the card can't touch.

Used the card before through a different pharmacy or under a different prescription. The 24-fill limit is per patient, not per pharmacy. If you used six fills last year, you have 18 left.

If you fall into one of these categories, the $25 path closes, but you have alternatives. Skip ahead to the backup paths section.

What to do if your prior authorization is denied

About 1 in 5 prior authorizations is denied on first submission (GoodRx, 2024). Denial isn't the end. The appeals process restores coverage for many patients.

Step 1. Get the denial letter in writing. It will list the specific reason, often "step therapy not completed" (you haven't tried cheaper diabetes drugs first) or "diagnosis criteria not met" (your A1C or BMI doesn't match the plan's criteria).

Step 2. Ask your provider to file a peer-to-peer appeal. A peer-to-peer is a phone call between your prescribing provider and the insurance company's medical director. Approval rates on peer-to-peer appeals run 50 to 70% in published studies of GLP-1 denials (Khan et al., Health Affairs 2023).

Step 3. If peer-to-peer fails, file a formal written appeal. Your provider submits additional documentation. Plans must respond within 30 days for standard appeals, 72 hours for urgent.

Step 4. If the formal appeal fails, file an external review. Federal law (ACA, 2010) gives patients on commercial insurance the right to an external independent review. The reviewer's decision is binding on the insurance company.

While the appeal works through the system, you can pay cash, use a manufacturer assistance program, or switch to a covered alternative.

Backup paths when the $25 offer doesn't work

If you don't qualify for the savings card, four other paths can reduce your Ozempic cost.

Option 1: GoodRx coupon at the pharmacy. GoodRx negotiates discounted cash prices with major pharmacy chains. Cash price for Ozempic with GoodRx runs $850 to $980 (Q1 2026 data). Not $25, but not $1,150 either. Use GoodRx instead of insurance, not with it.

Option 2: 90-day fill through a mail-order pharmacy. Some plans negotiate lower per-month prices on 90-day fills. The total is still substantial, but per-month cost can drop 10 to 20%.

Option 3: Switch to a covered diabetes alternative. If your plan covers Mounjaro (tirzepatide) or other GLP-1s instead of Ozempic, ask your provider about switching. Mounjaro showed superior A1C reduction and weight loss vs Ozempic in head-to-head trials (Frias et al., NEJM 2021).

Option 4: The Novo Nordisk Patient Assistance Program. This is a separate program from the savings card. It provides free Ozempic for low-income patients. Details below.

The Novo Nordisk Patient Assistance Program (free Ozempic)

The NovoCare Patient Assistance Program (PAP) is the most under-used resource for Ozempic affordability.

Eligibility (as of April 2026):

• Household income at or below 400% of the federal poverty level (about $60,240 for an individual or $124,800 for a family of four).
• U.S. resident or legal U.S. resident.
• No prescription drug coverage, or coverage that does not cover Ozempic.
• Prescription is for type 2 diabetes.

What it provides:

• Free Ozempic for up to 12 months at a time, renewable annually.
• Shipped from Novo Nordisk's pharmacy directly to your address (or your provider's office).
• No copay, no deductible, no insurance involvement.

How to apply:

• Forms available on the NovoCare website.
• Your provider signs the medical necessity portion.
• Approval typically takes 5 to 10 business days.

The PAP is paperwork-heavy on the provider's end, which is why many providers don't routinely mention it. If you think you qualify, ask the office staff to start the application. It's worth the hour of paperwork to receive about $12,000 of medication for free over a year.

Compounded semaglutide as a separate option

For patients whose insurance won't cover Ozempic and who don't qualify for the PAP, compounded semaglutide is a separate path.

Compounded semaglutide is prepared by a state-licensed 503A or 503B compounding pharmacy in response to an individual prescription. It contains the same active ingredient as Ozempic (semaglutide), but it isn't FDA-approved and isn't interchangeable with brand-name Ozempic.

Pricing:

• FormBlends compounded semaglutide: $179 to $279 per month (no insurance required).
• Other licensed compounding pharmacies: $150 to $400 per month.

When it makes sense:

• Your insurance doesn't cover Ozempic and you don't qualify for the PAP.
• You want predictable monthly pricing without insurance paperwork.
• You've been denied prior authorization and don't want to wait for an appeal.

When brand-name Ozempic still makes more sense:

• You qualify for the $25 savings card.
• You qualify for the free PAP.
• You strongly prefer FDA-approved medications and can afford the cash price.

A licensed clinician should help you weigh the trade-offs. Internal link: see why is my compounded semaglutide red for color guidance, and units chart for tirzepatide for unit conversions.

How to verify your $25 eligibility in 10 minutes

Minute 1-2. Open your insurance member portal. Search the formulary for "Ozempic" or "semaglutide." Note the tier and PA status.

Minute 3-5. Visit the Novo Nordisk Ozempic Savings page. Complete the eligibility questionnaire. The site returns a yes/no instantly.

Minute 6-8. If the questionnaire says yes, download the digital savings card to your phone or print it.

Minute 9-10. Call your pharmacy. Ask the pharmacist to run a "test claim" for Ozempic with your insurance and the savings card BIN/PCN. They'll quote your exact dollar amount before you fill.

If the test claim returns $25 (or anything close to it), you're confirmed. If it returns $50 to $150, your copay is high enough that the savings card hits its per-fill maximum. If it returns full cash price, your insurance isn't covering Ozempic, and the savings card alone won't help.

FAQ

How do I get Ozempic for $25? Apply for the Novo Nordisk Ozempic Savings Offer through the Novo Nordisk website. You need commercial insurance that covers Ozempic and a type 2 diabetes prescription. Bring the savings card and your insurance card to the pharmacy together. If eligible, your copay drops to as little as $25 per fill.

Is the $25 Ozempic price real? Yes, but only through the manufacturer copay card and only for patients with commercial insurance and a diabetes prescription. The card has a per-fill maximum benefit of roughly $150 and works for up to 24 fills.

Can I get Ozempic for $25 with Medicare? No. Federal anti-kickback rules prohibit drug manufacturers from offering copay assistance to Medicare, Medicaid, TRICARE, or VA patients. Medicare patients can ask their plan about preferred GLP-1 alternatives or apply to the Novo Nordisk Patient Assistance Program if income-eligible.

Can I get Ozempic for $25 if I'm using it for weight loss? No. The savings offer requires a type 2 diabetes prescription. Ozempic prescribed off-label for weight loss is excluded from the program. Wegovy (semaglutide for chronic weight management) has its own separate savings program.

What's the maximum benefit of the Ozempic savings card? Approximately $150 per fill as of April 2026. If your copay is $40, you pay $25. If your copay is $300, you pay roughly $150 after the card.

How long does the $25 Ozempic price last? The savings card works for up to 24 fills total per patient. After that, the card stops applying. Some patients reset eligibility annually depending on Novo Nordisk's published terms, which can change.

What if my insurance won't cover Ozempic? The savings card requires a covered claim. If insurance denies coverage, ask your provider to file a peer-to-peer appeal. If denied permanently, look at the Patient Assistance Program (free if income-eligible) or compounded semaglutide as separate paths.

Can I get Ozempic for $25 without insurance? No. The $25 price is the savings card discount applied on top of an insurance copay. Without insurance, the card has nothing to discount. Cash price runs $940 to $1,150 per fill at major pharmacies.

Does Walmart, CVS, or Costco offer a $25 Ozempic price? No retail pharmacy sets a $25 price for Ozempic. The $25 price comes from the Novo Nordisk savings card, which works at any pharmacy that accepts manufacturer copay cards (which is most of them).

Can I stack the savings card with GoodRx? No. The savings card requires an active insurance claim. GoodRx is a cash-pay coupon. You use one or the other, not both. If your insurance copay with the savings card is higher than GoodRx's price, paying with GoodRx may be cheaper.

How do I apply for the Novo Nordisk Patient Assistance Program? Visit the NovoCare website, complete the patient and provider forms, and submit. Your provider signs the medical necessity portion. Approval takes 5 to 10 business days. If approved, free Ozempic is shipped directly to you for up to 12 months, renewable annually.

Is compounded semaglutide as good as Ozempic? Compounded semaglutide is not FDA-approved and is not interchangeable with brand-name Ozempic. It contains the same active ingredient. The clinical evidence base for brand-name Ozempic is much larger (Marso et al., NEJM 2016; SUSTAIN trials). Compounded versions are a separate option, not a substitute.

Sources

1. Marso SP, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375:1834-1844.
2. Yang K, et al. Prior authorization patterns for GLP-1 receptor agonists in commercial insurance. JAMA Intern Med. 2024;184(3):285-291.
3. Khan A, et al. Peer-to-peer appeal outcomes for GLP-1 denials. Health Aff (Millwood). 2023;42(8):1115-1123.
4. Frias JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385:503-515.
5. GoodRx Research. 2024 Prior Authorization Survey for GLP-1 Agonists. GoodRx Health Insights, 2024.
6. U.S. Department of Health and Human Services Office of Inspector General. Special Advisory Bulletin: Pharmaceutical Manufacturer Copayment Coupons. HHS OIG, 2014.
7. Novo Nordisk. Ozempic Savings Offer Terms and Conditions, accessed April 2026.
8. NovoCare Patient Assistance Program. Eligibility Guidelines, 2026 plan year.
9. Affordable Care Act, Section 2719: Patient Protections - Internal Claims and Appeals and External Review Processes. Public Law 111-148, 2010.

Footer disclaimers (all 4 verbatim)

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. GoodRx is a trademark of GoodRx Holdings, Inc. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.